SEC Filings | Portage Biotech

View all our SEC Filings

Filing date	Description	Form	Filing Group	View
Nov 7, 2023	Form of prospectus reflecting facts events constituting substantive change from last form	424B3	Registration Statements	0001171843-23-006832.pdf 0001171843-23-006832.rtf 0001171843-23-006832.xls View HTML
Nov 7, 2023	EFFECT	EFFECT	Other	9999999995-23-003239.pdf 9999999995-23-003239.rtf 9999999995-23-003239.xls View HTML
Nov 3, 2023	CORRESP	CORRESP	Other	0001171843-23-006726.pdf 0001171843-23-006726.rtf 0001171843-23-006726.xls View HTML
Nov 3, 2023	UPLOAD	UPLOAD	Other	0000000000-23-012077.pdf 0000000000-23-012077.rtf View HTML
Oct 31, 2023	Registration statement for certain foreign private issuers	F-1	Registration Statements	0001171843-23-006549.pdf 0001171843-23-006549.rtf 0001171843-23-006549.xls View HTML
Oct 16, 2023	Notice of Exempt Offering of Securities	D	Other	0001567619-23-007479.pdf 0001567619-23-007479.rtf 0001567619-23-007479.xls View HTML
Oct 3, 2023	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	Registration Statements	0001171843-23-005984.pdf 0001171843-23-005984.rtf 0001171843-23-005984.xls View HTML
Oct 3, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001171843-23-006015.pdf 0001171843-23-006015.rtf 0001171843-23-006015.xls View HTML
Sep 29, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001171843-23-005940.pdf 0001171843-23-005940.rtf 0001171843-23-005940.xls View HTML
Sep 8, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001171843-23-005639.pdf 0001171843-23-005639.rtf 0001171843-23-005639.xls View HTML

Data provided by Kaleidoscope.